LEAP

Restricted Access | Catalogue record last updated: 2026/07/30

The Longitudinal European Autism Project (LEAP) aims to identify variability in autism in terms of behaviour, cognition, co-occurring conditions, outcomes, brain structure/function and genetics. LEAP is a multi-site study with 437 participants with ASD and 300 control participants with typical development or mild intellectual disability. To capture the diversity of autims, the LEAP study also focuses on previously under-represented groups in autism research, including autistic women and girls and indiduals with autism and intellectual disability.


Scientific field(s): Neuroscience and disorders of the nervous system

Participants and their families provide information about themselves using questionaires, interviews, paper-and-pencil or computer tasks and games, brain imaging and biological samples like saliva, blood or hair. The study also involves sensory measures (including auditory and tactile tasks).

Data processing level: Processed
Method(s): Whole-genome sequencing, Sample collection, Imaging, Interviews, Questionnaires, Cognitive tests

Clinical imaging: Diffusion tensor imaging (DTI), rs-fMRI, structural MRI, task fMRI, EEG.
Questionnaires and interviews.
Sample collection.
Most cognitive tests are administered using the computerised platform Psytools; some are paper-pencil tests.
Whole Genome Sequencing was also performed to obtain genetics data.

Condition(s)/Disease(s): Autism Spectrum Disorder (ASD)
Associated ressources:
  • 10.1186/s13229-017-0146-8: Loth, E. et al. The EU-AIMS Longitudinal European Autism Project (LEAP): design and methodologies to identify and validate stratification biomarkers for autism spectrum disorders. Mol. Autism 8, 24 (2017).
Catalogue record last updated: July 30, 2026, midnight